Belpointe Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,774
| Closed | -$802K | – | 813 |
|
|
2023
Q1 | $802K | Buy |
5,774
+342
| +6% | +$46K | 0.04% | 395 |
|
|
2022
Q4 | $737K | Sell |
5,432
-336
| -6% | -$42.1K | 0.04% | 396 |
|
|
2022
Q3 | $632K | Buy |
5,768
+858
| +17% | +$109K | 0.04% | 427 |
|
|
2022
Q2 | $648K | Sell |
4,910
-992
| -17% | -$130K | 0.04% | 399 |
|
|
2022
Q1 | $783K | Buy |
5,902
+1,694
| +40% | +$203K | 0.05% | 397 |
|
|
2021
Q4 | $491K | Sell |
4,208
-2,257
| -35% | -$266K | 0.03% | 529 |
|
|
2021
Q3 | $776K | Buy |
6,465
+3,317
| +105% | +$386K | 0.05% | 377 |
|
|
2021
Q2 | $377K | Sell |
3,148
-114
| -3% | -$12.5K | 0.03% | 587 |
|
|
2021
Q1 | $324K | Sell |
3,262
-196
| -6% | -$19.7K | 0.03% | 573 |
|
|
2020
Q4 | $346K | Sell |
3,458
-1,726
| -33% | -$183K | 0.03% | 508 |
|
|
2020
Q3 | $568K | Buy |
5,184
+2,804
| +118% | +$312K | 0.06% | 307 |
|
|
2020
Q2 | $252K | Buy |
2,380
+37
| +2% | +$3.82K | 0.03% | 460 |
|
|
2020
Q1 | $209K | Sell |
2,343
-37
| -2% | -$3.48K | 0.04% | 420 |
|
|
2019
Q4 | $238K | Sell |
2,380
-193
| -8% | -$18.2K | 0.03% | 490 |
|
|
2019
Q3 | $229K | Sell |
2,573
-342
| -12% | -$29.7K | 0.04% | 443 |
|
|
2019
Q2 | $241K | Sell |
2,915
-50
| -2% | -$3.92K | 0.05% | 371 |
|
|
2019
Q1 | $240K | Sell |
2,965
-67
| -2% | -$5.28K | 0.05% | 276 |
|
|
2018
Q4 | $230K | Buy |
3,032
+537
| +22% | +$41.9K | 0.06% | 318 |
|
|
2018
Q3 | $197K | Buy |
+2,495
| New | +$189K | 0.03% | 452 |
|
|
2018
Q2 | – | Sell |
-4,175
| Closed | -$292K | – | 340 |
|
|
2018
Q1 | $292K | Sell |
4,175
-1,429
| -25% | -$99K | 0.09% | 257 |
|
|
2017
Q4 | $389K | Buy |
5,604
+1,045
| +23% | +$70.5K | 0.09% | 285 |
|
|
2017
Q3 | $309K | Buy |
+4,559
| New | +$288K | 0.07% | 308 |
|
Other funds holding AZN
